CareLit Fachartikel

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial…

O Sommerburg, Y Yang, AA Rizio, B Loop, X You, M Kosinski, R Rendas-Baum, J Lekstrom-Himes, JS Elborn · Pneumologie · 2019 · Heft S 01 S 01

Dokument
1194850
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
O Sommerburg, Y Yang, AA Rizio, B Loop, X You, M Kosinski, R Rendas-Baum, J Lekstrom-Himes, JS Elborn
Ausgabe
Heft S 01 S 01 / 2019
Jahrgang 73
Seiten
–
Erschienen: 2019-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-1678165

Zusammenfassung

Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)

Schlagworte

Effects Tezacaftor Ivacaftor Treatment Patients Cystic Fibrosis F508Del F508Del-Cftr Patient-Reported Outcomes Phase Pneumologie